Cargando…

A Retrospective Analysis of Serious Adverse Events and Deaths in US-Based Lifestyle Clinical Trials for Cognitive Health

This retrospective analysis assessed the serious adverse events and deaths reported in lifestyle clinical trials designed to enhance cognitive health in older adults living in the United States. Data was collected from studies conducted between January 1, 2000, and July 19, 2023, using the ClinicalT...

Descripción completa

Detalles Bibliográficos
Autores principales: Key, Mickeal N., Shaw, Ashley R., Erickson, Kirk I., Burns, Jeffrey M., Vidoni, Eric D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557815/
https://www.ncbi.nlm.nih.gov/pubmed/37808675
http://dx.doi.org/10.1101/2023.09.27.23296243
_version_ 1785117153789214720
author Key, Mickeal N.
Shaw, Ashley R.
Erickson, Kirk I.
Burns, Jeffrey M.
Vidoni, Eric D.
author_facet Key, Mickeal N.
Shaw, Ashley R.
Erickson, Kirk I.
Burns, Jeffrey M.
Vidoni, Eric D.
author_sort Key, Mickeal N.
collection PubMed
description This retrospective analysis assessed the serious adverse events and deaths reported in lifestyle clinical trials designed to enhance cognitive health in older adults living in the United States. Data was collected from studies conducted between January 1, 2000, and July 19, 2023, using the ClinicalTrials.gov application programming interface. Our query revealed that 76% of these studies did not report trial results. The remaining studies with reported results were categorized under one of four intervention types: Cognitive/Behavioral, Exercise/Movement, Diet/Supplement, and Multi-modal. When all trial types are considered together, the results indicate that lifestyle clinical trials are safe, with no significant increase in relative risk of experiencing an SAE in an intervention group over a control group. And although the increase in relative risk of death in an intervention group over a control group was significant at 28% (X(2) (1, N = 36), p < 0.00688), the probability of death was not higher than the U.S. mortality rates by age. When assessing the data using intervention type, Diet/Supplement trials and Multi-modal trials both had an increase in relative risk of experiencing an SAE in the intervention over the control group, with Diet/Supplement trials at 16% (X(2) (1, N = 2), p < 0.0263) and Multi-modal trials at 365% (X(2) (1, N = 5), p < 0.000213). The Diet/Supplement trials also had an increased risk of death at 67% (X(2) (1, N = 2), p < 0.000197). These results should be taken with careful consideration. Due to such a low reporting rate, the 36 studies included in this analysis do not accurately represent the majority of lifestyle clinical trials conducted in the U.S. This study is valuable in that it highlights the importance of reporting clinical trial results, which will improve transparency in trial results and allow for more accurate assessments of safety in the growing field of cognitive aging and lifestyle interventions for older adults.
format Online
Article
Text
id pubmed-10557815
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-105578152023-10-07 A Retrospective Analysis of Serious Adverse Events and Deaths in US-Based Lifestyle Clinical Trials for Cognitive Health Key, Mickeal N. Shaw, Ashley R. Erickson, Kirk I. Burns, Jeffrey M. Vidoni, Eric D. medRxiv Article This retrospective analysis assessed the serious adverse events and deaths reported in lifestyle clinical trials designed to enhance cognitive health in older adults living in the United States. Data was collected from studies conducted between January 1, 2000, and July 19, 2023, using the ClinicalTrials.gov application programming interface. Our query revealed that 76% of these studies did not report trial results. The remaining studies with reported results were categorized under one of four intervention types: Cognitive/Behavioral, Exercise/Movement, Diet/Supplement, and Multi-modal. When all trial types are considered together, the results indicate that lifestyle clinical trials are safe, with no significant increase in relative risk of experiencing an SAE in an intervention group over a control group. And although the increase in relative risk of death in an intervention group over a control group was significant at 28% (X(2) (1, N = 36), p < 0.00688), the probability of death was not higher than the U.S. mortality rates by age. When assessing the data using intervention type, Diet/Supplement trials and Multi-modal trials both had an increase in relative risk of experiencing an SAE in the intervention over the control group, with Diet/Supplement trials at 16% (X(2) (1, N = 2), p < 0.0263) and Multi-modal trials at 365% (X(2) (1, N = 5), p < 0.000213). The Diet/Supplement trials also had an increased risk of death at 67% (X(2) (1, N = 2), p < 0.000197). These results should be taken with careful consideration. Due to such a low reporting rate, the 36 studies included in this analysis do not accurately represent the majority of lifestyle clinical trials conducted in the U.S. This study is valuable in that it highlights the importance of reporting clinical trial results, which will improve transparency in trial results and allow for more accurate assessments of safety in the growing field of cognitive aging and lifestyle interventions for older adults. Cold Spring Harbor Laboratory 2023-09-29 /pmc/articles/PMC10557815/ /pubmed/37808675 http://dx.doi.org/10.1101/2023.09.27.23296243 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.
spellingShingle Article
Key, Mickeal N.
Shaw, Ashley R.
Erickson, Kirk I.
Burns, Jeffrey M.
Vidoni, Eric D.
A Retrospective Analysis of Serious Adverse Events and Deaths in US-Based Lifestyle Clinical Trials for Cognitive Health
title A Retrospective Analysis of Serious Adverse Events and Deaths in US-Based Lifestyle Clinical Trials for Cognitive Health
title_full A Retrospective Analysis of Serious Adverse Events and Deaths in US-Based Lifestyle Clinical Trials for Cognitive Health
title_fullStr A Retrospective Analysis of Serious Adverse Events and Deaths in US-Based Lifestyle Clinical Trials for Cognitive Health
title_full_unstemmed A Retrospective Analysis of Serious Adverse Events and Deaths in US-Based Lifestyle Clinical Trials for Cognitive Health
title_short A Retrospective Analysis of Serious Adverse Events and Deaths in US-Based Lifestyle Clinical Trials for Cognitive Health
title_sort retrospective analysis of serious adverse events and deaths in us-based lifestyle clinical trials for cognitive health
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557815/
https://www.ncbi.nlm.nih.gov/pubmed/37808675
http://dx.doi.org/10.1101/2023.09.27.23296243
work_keys_str_mv AT keymickealn aretrospectiveanalysisofseriousadverseeventsanddeathsinusbasedlifestyleclinicaltrialsforcognitivehealth
AT shawashleyr aretrospectiveanalysisofseriousadverseeventsanddeathsinusbasedlifestyleclinicaltrialsforcognitivehealth
AT ericksonkirki aretrospectiveanalysisofseriousadverseeventsanddeathsinusbasedlifestyleclinicaltrialsforcognitivehealth
AT burnsjeffreym aretrospectiveanalysisofseriousadverseeventsanddeathsinusbasedlifestyleclinicaltrialsforcognitivehealth
AT vidoniericd aretrospectiveanalysisofseriousadverseeventsanddeathsinusbasedlifestyleclinicaltrialsforcognitivehealth
AT keymickealn retrospectiveanalysisofseriousadverseeventsanddeathsinusbasedlifestyleclinicaltrialsforcognitivehealth
AT shawashleyr retrospectiveanalysisofseriousadverseeventsanddeathsinusbasedlifestyleclinicaltrialsforcognitivehealth
AT ericksonkirki retrospectiveanalysisofseriousadverseeventsanddeathsinusbasedlifestyleclinicaltrialsforcognitivehealth
AT burnsjeffreym retrospectiveanalysisofseriousadverseeventsanddeathsinusbasedlifestyleclinicaltrialsforcognitivehealth
AT vidoniericd retrospectiveanalysisofseriousadverseeventsanddeathsinusbasedlifestyleclinicaltrialsforcognitivehealth